Study of the Effect of inhaled Short Acting Beta 2 Agonist(procaterol) on Breathlessness on Exertion in COPD patients.
Not Applicable
Not yet recruiting
- Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
- Registration Number
- JPRN-UMIN000007543
- Lead Sponsor
- Tokyo Women's Medical University Tohoku University Hospital Wakayama Medical University Tohoku Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
A patient will not be eligible for inclusion in this study if any of the following criteria 1. There is a current diagnosis of asthma, in the opinion of the investigator 2. Patients with contraindication of procaterol inhalation. 3. The investigator judge to exclude
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method severity of Breathlessness in exertions(Shortness of Breath Questionaire)
- Secondary Outcome Measures
Name Time Method Activities of Daily Living(ADL) using Actimarker